Status:
COMPLETED
Diclofenac Potassium Alone Versus Diclofenac Potassium With Hyoscine-N-butyl Bromide (HBB in Endoscopy
Lead Sponsor:
Aljazeera Hospital
Collaborating Sponsors:
Cairo University
Conditions:
Pain
Eligibility:
FEMALE
20-40 years
Phase:
NA
Brief Summary
Diclofenac is a proven, commonly prescribed nonsteroidal anti-inflammatory drug (NSAID) that has analgesic, anti-inflammatory, and antipyretic properties, and has been shown to be effective in treatin...
Detailed Description
Diclofenac is a proven, commonly prescribed nonsteroidal anti-inflammatory drug (NSAID) that has analgesic, anti-inflammatory, and antipyretic properties, and has been shown to be effective in treatin...
Eligibility Criteria
Inclusion
- 1\. Patients indicated for diagnostic hysteroscopy including infertility, bleeding, suspected intrauterine pathologies (eg polypi , septea) 2. Reproductive age 20 - 40yrs
Exclusion
- 1\. Menopausal and amenorrhic patients 2. Contraindication to office hysteroscopy such as:- pelvic inflammatory disease, marked cervical stenosis, pregnancy
Key Trial Info
Start Date :
February 16 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2020
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT04125771
Start Date
February 16 2020
End Date
October 1 2020
Last Update
November 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Algazeerah and Kasralainy hospital
Giza, Egypt